Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). [electronic resource]
Producer: 20070405Description: 82-87 p. digitalISSN:- 0923-7534
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Pancreatic Neoplasms -- drug therapy
- Quality of Life
- Survival Rate
- Time Factors
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.